A recent study has demonstrated a protective effect of GCNT2/I-branched glycans in melanomas, with experiments in vitro and in vivo demonstrating that GCNT2/I-branched glycans promoted melanoma growth and survival through IGF-1 and ECM-mediated signaling pathways (25). This evidence concerns the gene IGF1 and melanoma.